VTV Therapeutics reports lower net loss after decreasing expenses
High Point biopharma VTVT sees positive results for treatment of mild Alzheimer’s, cuts losses.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
